Joanna Hilt

Statistics

Publications

Citations

695

H-Index

Active since

2008

Affiliations

NIHR Leeds Musculoskeletal Biomedical Research Unit(Current)

Institute of Rheumatology

Poznan University of Medical Sciences

University of Leeds

Samsung (South Korea)

Joanna Hilt is an author at NIHR Leeds Musculoskeletal Biomedical Research Unit specializing in rheumatology, rheumatoid arthritis, and rheumatoid arthritis pharmacotherapy.

Publications per year

2008–2017

Publications

Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial

Roy Fleischmann, Eduardo Mysler, Stephen Hall et al. · The Lancet · 2017 · 496 citations

Medicine, Pharmacology, Pharmacotherapy +12

Long-term efficacy and safety in patients with rheumatoid arthritis continuing on SB4 or switching from reference etanercept to SB4

Paul Emery, Jiří Vencovský, Anna Sylwestrzak et al. · Annals of the Rheumatic Diseases · 2017 · 110 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Increased Responsiveness to Toll‐Like Receptor 4 Stimulation in Peripheral Blood Mononuclear Cells from Patients with Recent Onset Rheumatoid Arthritis

M. L. Kowalski, Anna Wolska, J Grzegorczyk et al. · Mediators of Inflammation · 2008 · 72 citations · Full text

Life Sciences, Immunology, Internal Medicine +17

THU0150 Long-Term Safety and Efficacy of SB4 (Etanercept Biosimilar) in Patients with Rheumatoid Arthritis: Comparison between Continuing SB4 and Switching from Etanercept Reference Product To SB4

Paul Emery, Jiří Vencovský, Anna Sylwestrzak et al. · Annals of the Rheumatic Diseases · 2016 · 17 citations

Medicine, Clinical Sciences, Pharmacotherapy +15

1–4 of 4